Evidence map›Paper›PMID 31734993›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Study of local application of CpG-oligodeoxynucleotide combined with 4-1BB monoclonal antibody to treat hepatoma- bearing mice].

S Z Ma, C Q Zhang, F B Kang, D X Sun

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

S Z MaChengde Medical College, Chengde 067000, China; The Chinese People's Liberation Army 980th Hospital Logistic Support Forces Army Center of Diagnosis and Treatment of Liver Disease, Shijiazhuang 050082, China.
C Q ZhangChengde Medical College, Chengde 067000, China; The Chinese People's Liberation Army 980th Hospital Logistic Support Forces Army Center of Diagnosis and Treatment of Liver Disease, Shijiazhuang 050082, China.
F B KangThe Chinese People's Liberation Army 980th Hospital Logistic Support Forces Army Center of Diagnosis and Treatment of Liver Disease, Shijiazhuang 050082, China.
D X SunThe Chinese People's Liberation Army 980th Hospital Logistic Support Forces Army Center of Diagnosis and Treatment of Liver Disease, Shijiazhuang 050082, China.
Chinese People's Liberation Army · CNPeople's Liberation Army 401 Hospital · CN

Funding

National Natural Science Foundation of China 30571667
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyAnimalsAntibodies, MonoclonalCarcinoma, HepatocellularInterferon-gammaInterleukin-12Liver NeoplasmsMaleMiceMice, Inbred BALB COligodeoxyribonucleotidesRandom AllocationAntibodies, MonoclonalIFNG protein, mouseInterferon-gammaInterleukin-12Oligodeoxyribonucleotides4-1BBCarcinoma, hepatocellularCpG oligodeoxynucleotideImmunotherapyRemote tumor

Identifiers

PMID31734993
PMCPMC12814212
OpenAlexW2990343967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.